Investors keen on the healthcare sector’s diagnostics and research vertical will find Neogen Corporation (NASDAQ: NEOG) an intriguing prospect, especially given its potential upside of 36.18%. Based in Lansing, Michigan,..
Investors looking to capitalize on growth within the healthcare sector should pay close attention to U.S. Physical Therapy, Inc. (NYSE: USPH). With a market cap of $1.36 billion, this Houston-based..
AtriCure, Inc. (NASDAQ: ATRC), a leader in the medical instruments and supplies industry, is capturing investor attention with a compelling narrative of growth potential and innovation in cardiac surgery solutions...
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) has captured investor attention in the healthcare sector, specifically within the drug manufacturers’ niche. Known for its branded and generic pharmaceutical products, ANI Pharmaceuticals offers..
Vera Therapeutics, Inc. (NASDAQ: VERA), a burgeoning name in the biotechnology sector, is capturing investor interest with its promising potential upside of 106.04%. This clinical-stage biotechnology company is focused on..
ImmunityBio, Inc. (NASDAQ: IBRX), a pioneering biotechnology firm based in San Diego, California, has captured investor attention with a staggering potential upside of 303.16%. This promising figure, coupled with its..
In the vibrant and competitive landscape of biotechnology, Ascentage Pharma Group International (AAPG) has positioned itself as a significant player in the healthcare sector. With a market capitalization of $3.71..
Pediatrix Medical Group, Inc. (MD), a key player in the healthcare sector, operates within the medical care facilities industry, providing essential specialized care for newborns, expectant mothers, and pediatric patients..
Kestra Medical Technologies, Ltd. (KMTS) is garnering attention in the healthcare sector, particularly within the Medical Instruments & Supplies industry. Based in Kirkland, Washington, this U.S.-based company is making waves..
MoonLake Immunotherapeutics (NASDAQ: MLTX), a rising star in the biotechnology sector, has captured investor attention with its promising pipeline of therapies targeting inflammatory skin and joint diseases. Headquartered in Zug,..
GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the Diagnostics & Research sector, is capturing attention with its robust 45.60% revenue growth and a market capitalization of $3.45 billion...
UFP Technologies, Inc. (NASDAQ: UFPT), a prominent player in the healthcare sector, specifically within the medical devices industry, has caught the attention of investors with its robust growth metrics and..
Amedisys Inc (NASDAQ: AMED), a prominent player in the healthcare sector, continues to capture investor interest with its strong focus on home health services, hospice care, and high acuity care...
Veracyte, Inc. (VCYT), a prominent player in the healthcare sector, specializes in groundbreaking diagnostic solutions that span multiple types of cancer. With a market capitalization of $2.84 billion, the company..
Alvotech (NASDAQ: ALVO), a Luxembourg-based biopharmaceutical company, continues to pique investor interest with its innovative approach to biosimilar medicines and a remarkable potential upside. Operating in the highly competitive healthcare..
PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a key player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors with its promising position in the surgical robotics..
Arcellx, Inc. (NASDAQ: ACLX), a pioneering biotechnology firm based in Redwood City, California, is making significant strides in the healthcare sector with its innovative immunotherapy developments. Despite a recent slight..
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX), a prominent player in the healthcare sector, is drawing attention from investors with a robust market capitalization of $3.31 billion. The company, rooted in the..
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a prominent player in the biotech sector, is drawing investor attention with its promising therapeutic pipeline and a market cap of $3.64 billion. The company,..
Travere Therapeutics, Inc. (NASDAQ: TVTX) stands out in the biotechnology sector as a promising player with a focus on rare kidney and metabolic diseases. With a market capitalization of $2.33..
